Report Describes Case of Improved Outcome in MM With Personalized Medicine
March 6th 2021Researchers describe the case of an older patient who underwent myeloma drug sensitivity testing as part of an effort to identify the therapies most likely to produce a response in this difficult-to-treat population.
Care Disparities Persist Among White, Minority Patients With Rheumatoid Arthritis
March 4th 2021A recent study found that patients living in an an area with low socioeconomic status were less likely to be prescribed biological disease-modifying antirheumatic drugs if they were considered low-income and were male and African American.
Genetic Picture Emerges of Polycystic Kidney Disease in Ireland
February 27th 2021Cutting-edge genetic tools diagnosed 83% of Irish patients with polycystic kidney disease (PKD), identified 36 novel variants, and discovered that seemingly unrelated individuals with the same variant likely inherited it from a common ancestor.
Understanding Mortality Risk in Pediatric Pulmonary Arterial Hypertension
February 26th 2021The study examined various factors used in an internationally developed risk stratification strategy to assess which ones had evidence of being significant in determining a child’s prognosis from the deadly disease.
Publicly Insured Patients With Asthma Treated Less Often With Biologics
February 16th 2021Treatment of asthma with biologics was lower for those on public health insurance compared with those who had private insurance, with Blacks underrepresented relative to Whites in publicly insured visits where biologic treatment is used.
TKI Discontinuation Found to Benefit PROs in CML, Study Says
February 6th 2021Results from a new clinical trial suggest that discontinuation of tyrosine kinase inhibitors (TKIs) is safe, feasible and is associated with improvements in patient-related outcomes (PROs) in chronic myeloid leukemia (CML).
Assessing Disease Severity in AD, Psoriasis Through Transepidermal Water Loss, Temperature
February 2nd 2021Temperature and transepidermal water loss can serve as objective measures to help determine severity of cases of atopic dermatitis (AD) psoriasis and identify which patients need intensive treatment, according to a new study.